The use and safety risk of repurposed drugs for COVID-19 patients: lessons learned utilizing the Food and Drug Administration’s Adverse Event Reporting System

Objectives: This study was designed to assess the disproportionality analyses of adverse drug reactions (ADRs) related to hydroxychloroquine and remdesivir and how ADR reporting fluctuated during the COVID-19 pandemic. Methods: A retrospective observational study was conducted utilizing the Food and...

Full description

Bibliographic Details

Published in:	Saudi Pharmaceutical Journal
Main Authors:	Deemah S. Alsuhaibani, Heba H. Edrees, Thamir M Alshammari
Format:	Article
Language:	English
Published:	Springer 2023-07-01
Subjects:	COVID-19 Hydroxychloroquine Remdesivir QT prolongation FAERS
Online Access:	http://www.sciencedirect.com/science/article/pii/S1319016423001494